Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2003

01.11.2003 | Case Report

Prenatal diagnosis of thanatophoric dysplasia in the second trimester: ultrasonography and other diagnostic modalities

verfasst von: Zeki Sahinoglu, Mehmet Uludogan, Ayse Gurbuz, Ates Karateke

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2003

Einloggen, um Zugang zu erhalten

Abstract.

Thanatophoric dysplasia is the most common type of neonatal lethal osteochondrodysplasias, with an estimated frequency of nearly of 1 in 20,000 births. It is a disorder characterized by extremely short ribs, tubular bones and macrocephaly. The prenatal diagnosis of thanatophoric dysplasia has been well established by ultrasonography in the second trimester; however it is not always possible to differentiate the thanatophoric dysplasia fetuses from the others with skeletal dysplasias like fibrochondrogenesis or atelosteogenesis by ultrasonography. Recently, mutations in the fibroblast growth factor receptor 3 gene, located on the short arm of chromosome 4 have been identified as a cause of thanatophoric dysplasia. In this article we described the prenatal diagnosis of two fetuses with thanatophoric dysplasia at 18 and 24 weeks of gestation by ultrasonography. Postpartum radiological and histological analysis confirmed our prenatal diagnosis. Our purpose was to remind the differential prenatal diagnosis with other skeletal dysplasias and new prenatal diagnostic modalities.
Literatur
1.
Zurück zum Zitat Baker KM, Olson DS, Harding CO, Pauli RM (1997) Long term survival in typical thanatophoric dysplasia type 1. Am J Med Genet 70:427–436CrossRefPubMed Baker KM, Olson DS, Harding CO, Pauli RM (1997) Long term survival in typical thanatophoric dysplasia type 1. Am J Med Genet 70:427–436CrossRefPubMed
2.
Zurück zum Zitat Bellus G, Hefferon TW, Ortiz de Luna RI, Hecht JT, Horton WA, Machado M, Kaitila I, McIntosh I, Francomano C (1995) Achondroplasia is defined by recurrent G380R mutations of FGFR-3. Am J Hum Genet 56:368–373PubMedPubMedCentral Bellus G, Hefferon TW, Ortiz de Luna RI, Hecht JT, Horton WA, Machado M, Kaitila I, McIntosh I, Francomano C (1995) Achondroplasia is defined by recurrent G380R mutations of FGFR-3. Am J Hum Genet 56:368–373PubMedPubMedCentral
3.
Zurück zum Zitat Bonaventure J, Rousseau F, Legeai-Mallet, Le Merrer M, Munnich M, Maroteaux P (1996) Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for chondroplasia, hypochondroplasia, and thanatophoric dwarfism. Am J Med Genet 63:148–154CrossRefPubMed Bonaventure J, Rousseau F, Legeai-Mallet, Le Merrer M, Munnich M, Maroteaux P (1996) Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for chondroplasia, hypochondroplasia, and thanatophoric dwarfism. Am J Med Genet 63:148–154CrossRefPubMed
4.
Zurück zum Zitat De Biasio P, Prefumo F, Baffico M, Baldi M, Priolo M, Lerone M, Toma P, Venturini PL (2000) Sonographic and molecular diagnosis of thanatophoric dysplasia type I at 18 weeks of gestation. Prenat Diagn 20:835–837CrossRefPubMed De Biasio P, Prefumo F, Baffico M, Baldi M, Priolo M, Lerone M, Toma P, Venturini PL (2000) Sonographic and molecular diagnosis of thanatophoric dysplasia type I at 18 weeks of gestation. Prenat Diagn 20:835–837CrossRefPubMed
5.
Zurück zum Zitat Escobar LF, Bixler D, Weaver DD, Padilla LM, Golichowski A (1990) Bone dysplasias: the prenatal diagnostic challenge. Am J Med Genet 36:488–494CrossRefPubMed Escobar LF, Bixler D, Weaver DD, Padilla LM, Golichowski A (1990) Bone dysplasias: the prenatal diagnostic challenge. Am J Med Genet 36:488–494CrossRefPubMed
6.
Zurück zum Zitat Givol D, Yayon A (1992) Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J 6:3362–3369CrossRefPubMed Givol D, Yayon A (1992) Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J 6:3362–3369CrossRefPubMed
7.
Zurück zum Zitat Goncalves L, Jeanty P (1994) Fetal biometry of skeletal dysplasias: a multicentric study. J Ultrasound Med 13:767–775CrossRefPubMed Goncalves L, Jeanty P (1994) Fetal biometry of skeletal dysplasias: a multicentric study. J Ultrasound Med 13:767–775CrossRefPubMed
8.
Zurück zum Zitat Guu WS, Hsu TT, Chang SY, Chang JC, Huang CC (1996) Second trimester of thanatophoric dysplasia. Chang Keng I Hsueh 19:258–263PubMed Guu WS, Hsu TT, Chang SY, Chang JC, Huang CC (1996) Second trimester of thanatophoric dysplasia. Chang Keng I Hsueh 19:258–263PubMed
9.
Zurück zum Zitat Hersh JH, Angle B, Pietrantoni M, Cook VD; Spinnato JA, Clark AL, Kurtzman JT, Bendon RW, Gerassimides A (1998) Predictive value of fetal ultrasonography in the diagnosis of a lethal skeletal dysplasia. South Med J 91:1137–1142CrossRefPubMed Hersh JH, Angle B, Pietrantoni M, Cook VD; Spinnato JA, Clark AL, Kurtzman JT, Bendon RW, Gerassimides A (1998) Predictive value of fetal ultrasonography in the diagnosis of a lethal skeletal dysplasia. South Med J 91:1137–1142CrossRefPubMed
10.
Zurück zum Zitat Horton WA, Harris DJ, Collins DL (1983) Discordance for the Kleeblattschaedel anomaly in monozygotic twins with thanatophoric dysplasia. Am J Med Genet 15:97–101CrossRefPubMed Horton WA, Harris DJ, Collins DL (1983) Discordance for the Kleeblattschaedel anomaly in monozygotic twins with thanatophoric dysplasia. Am J Med Genet 15:97–101CrossRefPubMed
11.
Zurück zum Zitat Johnson DE, Williams LT (1993) Structural and functional diversity in the FGF receptor multigene family. Adv Cancer 60:1–41 Johnson DE, Williams LT (1993) Structural and functional diversity in the FGF receptor multigene family. Adv Cancer 60:1–41
12.
Zurück zum Zitat Langer LO, Yang SS, Hall JG, Sommer A, Kottamasu SR, Golabi M, Krassikof N (1987) Thanatophoric dysplasia and cloverleaf skull [review]. Am J Med Genet 3:167–179CrossRef Langer LO, Yang SS, Hall JG, Sommer A, Kottamasu SR, Golabi M, Krassikof N (1987) Thanatophoric dysplasia and cloverleaf skull [review]. Am J Med Genet 3:167–179CrossRef
13.
Zurück zum Zitat Maroteaux P, Lamy M, Robert JM (1967) Lenanisme thanatophore. Presse Med 75:2519–2524 Maroteaux P, Lamy M, Robert JM (1967) Lenanisme thanatophore. Presse Med 75:2519–2524
14.
Zurück zum Zitat Nerlich AG, Freisinger P, Bonaventure J (1996) Radiological and histological variants of thanatophoric dysplasia are associated with common mutations in FGFR-3. Am L Med Genet 63:155–160CrossRef Nerlich AG, Freisinger P, Bonaventure J (1996) Radiological and histological variants of thanatophoric dysplasia are associated with common mutations in FGFR-3. Am L Med Genet 63:155–160CrossRef
15.
Zurück zum Zitat Ornoy A, Borochowitz Z, Lachman R, Rimoin DL (1988) Atlas of fetal skeletal radiology. Year Book, Chicago, pp 19–94 Ornoy A, Borochowitz Z, Lachman R, Rimoin DL (1988) Atlas of fetal skeletal radiology. Year Book, Chicago, pp 19–94
16.
Zurück zum Zitat Pokharel RK, Alimsardjono H, Takeshima Y, Nakamura H, Naritomi K, Hirose S, Onishi S, Matsuo M (1996) Japanese cases of type 1 thanatophoric dysplasia exclusively carry a C to T transition at nucleotide 742 of the fibroblast growth factor receptor 3 gene. Biochem Biophys Res Commun 227:236–239CrossRefPubMed Pokharel RK, Alimsardjono H, Takeshima Y, Nakamura H, Naritomi K, Hirose S, Onishi S, Matsuo M (1996) Japanese cases of type 1 thanatophoric dysplasia exclusively carry a C to T transition at nucleotide 742 of the fibroblast growth factor receptor 3 gene. Biochem Biophys Res Commun 227:236–239CrossRefPubMed
17.
Zurück zum Zitat Rahemtullah A, McGillivray B, Wilson RD (1997) Suspected skeletal dysplasia: femur length to abdominal circumference ratio can be used in ultrasonographic prediction of fetal outcome. Am J Obstet Gynecol 177:864–869CrossRefPubMed Rahemtullah A, McGillivray B, Wilson RD (1997) Suspected skeletal dysplasia: femur length to abdominal circumference ratio can be used in ultrasonographic prediction of fetal outcome. Am J Obstet Gynecol 177:864–869CrossRefPubMed
18.
Zurück zum Zitat Ramus RM, Martin LB, Twickler DM (1998) Ultrasonographic prediction of fetal outcome in suspected skeletal dysplasias with use of the femur length-to-abdominal circumference ratio. Am J Obstet Gynecol 179:1348–1352CrossRefPubMed Ramus RM, Martin LB, Twickler DM (1998) Ultrasonographic prediction of fetal outcome in suspected skeletal dysplasias with use of the femur length-to-abdominal circumference ratio. Am J Obstet Gynecol 179:1348–1352CrossRefPubMed
19.
Zurück zum Zitat Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet J-M, Maroteaux P, Le Merrer M, Munnich A (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371:252–254CrossRefPubMed Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet J-M, Maroteaux P, Le Merrer M, Munnich A (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371:252–254CrossRefPubMed
20.
Zurück zum Zitat Rousseau F, Saugier P, Le Merrer M, Munnich A, Delezoide A-L, Maroteaux P, Bonaventure J (1995) Stop codon FGFR-3 mutations in thanatophoric dysplasia type I. Nat Genet 10:11–12CrossRefPubMed Rousseau F, Saugier P, Le Merrer M, Munnich A, Delezoide A-L, Maroteaux P, Bonaventure J (1995) Stop codon FGFR-3 mutations in thanatophoric dysplasia type I. Nat Genet 10:11–12CrossRefPubMed
21.
Zurück zum Zitat Sawai H, Komori S, Ida A, Henmi T, Besso T, Koyama K (1999) Prenatal diagnosis of thanatophoric dysplasia by mutational analysis of the fibroblast growth factor receptor 3 gene and a proposed correction of previously published PCR results. Prenat Diagn 19:21–24CrossRefPubMed Sawai H, Komori S, Ida A, Henmi T, Besso T, Koyama K (1999) Prenatal diagnosis of thanatophoric dysplasia by mutational analysis of the fibroblast growth factor receptor 3 gene and a proposed correction of previously published PCR results. Prenat Diagn 19:21–24CrossRefPubMed
22.
Zurück zum Zitat Shiang R. Thompson LM, Zhu Y-Z, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ (1994) Mutations in the transmembrane domain of FGFR-3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335–342CrossRefPubMed Shiang R. Thompson LM, Zhu Y-Z, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ (1994) Mutations in the transmembrane domain of FGFR-3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335–342CrossRefPubMed
23.
Zurück zum Zitat Tavormina PL, Rimoin DL, Cohn DH, Zhu YZ, Shiang R, Wasmuth JJ (1995) Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I. Hum Mol Genet 4:2175–2177CrossRefPubMed Tavormina PL, Rimoin DL, Cohn DH, Zhu YZ, Shiang R, Wasmuth JJ (1995) Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I. Hum Mol Genet 4:2175–2177CrossRefPubMed
24.
Zurück zum Zitat Taybi H, Lachman RS (1996) Radiology of syndromes, metabolic disorders, and skeletal dysplasias, 4th edn. Mosby, St. Louis, pp 939–945 Taybi H, Lachman RS (1996) Radiology of syndromes, metabolic disorders, and skeletal dysplasias, 4th edn. Mosby, St. Louis, pp 939–945
25.
Zurück zum Zitat Tretter AE, Saunders RC, Meyers CM, Dungan JS, Grumbach K, Sun CC, Campbell AB, Wulfsberg EA (1998) Antenatal diagnosis of lethal dysplasias. Am J Med Genet 75:518–522CrossRefPubMed Tretter AE, Saunders RC, Meyers CM, Dungan JS, Grumbach K, Sun CC, Campbell AB, Wulfsberg EA (1998) Antenatal diagnosis of lethal dysplasias. Am J Med Genet 75:518–522CrossRefPubMed
26.
Zurück zum Zitat Wilcox WR, Tavormina PL, Krakow D, Kitoh H, Lachman RS, Wasmuth JJ, Thompson LM, Rimoin DL (1998) Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia. Am J Med Genet 78:274–281CrossRefPubMed Wilcox WR, Tavormina PL, Krakow D, Kitoh H, Lachman RS, Wasmuth JJ, Thompson LM, Rimoin DL (1998) Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia. Am J Med Genet 78:274–281CrossRefPubMed
Metadaten
Titel
Prenatal diagnosis of thanatophoric dysplasia in the second trimester: ultrasonography and other diagnostic modalities
verfasst von
Zeki Sahinoglu
Mehmet Uludogan
Ayse Gurbuz
Ates Karateke
Publikationsdatum
01.11.2003
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2003
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-002-0417-1

Weitere Artikel der Ausgabe 1/2003

Archives of Gynecology and Obstetrics 1/2003 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.